News

Read the latest news and updates from The Pirbright Institute.

Go to main content

Filters

Filters

Enter keywords

Select virus

Select month

Select researcher

Featured news

Young scientist shining a light on an egg in a green tray in a dark room.

CRISPR chicken cell study boosts potential for vaccine development

Scientists at The Pirbright Institute have created gene-edited chicken cells that produce significantly higher yields of influenza A virus and Newcastle disease virus (NDV). Poultry vaccines are the mainstay of disease prevention in the global poultry production industry, worth an estimated $420…

An empty CL3 laboratory at The Pirbright Institute. There are three Biological safety cabinets, two of which have yellow gloves that go into the cabinet

Launch of the Biorisk Advisor Training course

A new training course developed at The Pirbright Institute has been approved by the Royal Society of Biology (RSB) for continuing professional development (CPD) purposes. This approval recognises and underscores its relevance and value to those in the field and marks a significant milestone for…

Latest news

pigs sleeping ASF african swine fever Pirbright

Centralised Immunogen Strategy for PRRSV Protection

Scientists at The Pirbright Institute have successfully developed a novel modified live vaccine candidate for porcine reproductive and respiratory syndrome virus type 1 (PRRSV-1), designed using a centralised immunogen approach. The research is a step towards achieving broader, more consistent…